---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-22-000032"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2022-05-25T23:59:59+00:00"
generated_at: "2026-06-25T07:17:13.639189+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Clover Health appoints Scott J. Leffler as CFO effective August 2022

## Summary
- Scott J. Leffler, former CFO of Sotera Health, named permanent CFO; starts August 2022.
- Interim CFO Mark C. Herbers will assist transition after Leffler joins.
- Base salary $500,000; target bonus 75%; one-time RSU grant worth $12,000,000 with graded vesting.
- Signing bonus of $100,000 with repayment clause for voluntary termination within 12 months.

## SEC filing metadata
- accession: 0001801170-22-000032
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2022-05-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117022000032/0001801170-22-000032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117022000032/clov-20220525.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-22-000032
- JSON: https://secwatch.observer/filing/0001801170-22-000032.json
- Plain text: https://secwatch.observer/filing/0001801170-22-000032.txt

## Key facts
- Executive change
  Scott J. Leffler was appointed as Chief Financial Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE.
  - Action: appointed
  - Role: Chief Financial Officer
  source text: Scott J. Leffler will become Chief Financial Officer of the Company, to serve as the Company’s principal financial officer and principal accounting officer, effective upon the commencement of his employment with the Company in August 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1801170/000180117022000032/0001801170-22-000032-index.htm
- Executive change
  Mark C. Herbers changed role as Interim Chief Financial Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE.
  - Action: succeeded
  - Role: Interim Chief Financial Officer
  source text: Mr. Leffler will succeed Mark C. Herbers, the Company’s current Interim Chief Financial Officer, who will continue in his role as Interim Chief Financial Officer until Mr. Leffler joins the Company and thereafter will assist in the transition.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1801170/000180117022000032/0001801170-22-000032-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.